• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1955年至1994年芬兰癌症患者的生存率。

Survival of cancer patients in Finland 1955-1994.

作者信息

Dickman P W, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, Söderman B, Teppo L

机构信息

Finnish Cancer Registry, Helsinki.

出版信息

Acta Oncol. 1999;38 Suppl 12:1-103. doi: 10.1080/028418699432996.

DOI:10.1080/028418699432996
PMID:10225326
Abstract

INTRODUCTION

The study of survival of cancer patients is essential for monitoring the effectiveness of cancer control. The previous monograph describing cancer patient survival in Finland was published by the Finnish Cancer Registry in 1981 and covered patients diagnosed in 1953-1974. This new supplement assesses cancer patient survival up to the year 1995.

MATERIAL AND METHODS

The study includes over 560000 tumours registered at the Finnish Cancer Registry with a date of diagnosis between 1955 and 1994. Patients were followed up to the end of 1995. Trends in relative survival rates are studied over four 10-year diagnostic periods from 1955 to 1994. In addition, detailed results are presented for patients diagnosed during 1985-1994, including relative survival rates tabulated by stage, sex, and age. Additional sections describe differences in cancer patient survival according to social class and region of residence and a comparison of cancer patient survival in Finland to other European countries.

RESULTS

Patient survival improved over time for almost all anatomical sites. The main exception is in cancer of the cervix uteri, where patient survival has decreased slightly from 1965-1974 to 1985-1994 due to the selective prevention of less aggressive tumours through cytologic screening. Very few differences in patient survival are observed between males and females. A substantial improvement in survival can be seen for childhood cancers.

CONCLUSION

The increasing survival rates reflect improvements that have taken place in various areas of cancer control, from health education and early diagnosis to treatment and aftercare. This study provides valuable reference information for both clinicians and health administrators, as well as a baseline for more detailed studies of patient survival for individual anatomical sites.

摘要

引言

癌症患者生存率的研究对于监测癌症控制效果至关重要。芬兰癌症登记处曾于1981年出版过一部描述芬兰癌症患者生存率的专著,涵盖了1953年至1974年诊断的患者。本新补编评估了截至1995年的癌症患者生存率。

材料与方法

该研究纳入了芬兰癌症登记处登记的超过560000例肿瘤病例,诊断日期在1955年至1994年之间。对患者随访至1995年底。研究了1955年至1994年四个10年诊断期内相对生存率的趋势。此外,还给出了1985年至1994年诊断患者的详细结果,包括按分期、性别和年龄列出的相对生存率。其他部分描述了根据社会阶层和居住地区划分的癌症患者生存率差异,以及芬兰癌症患者生存率与其他欧洲国家的比较。

结果

几乎所有解剖部位的患者生存率都随时间有所提高。主要例外是子宫颈癌,由于通过细胞学筛查选择性预防了侵袭性较小的肿瘤,从1965 - 1974年到1985 - 1994年患者生存率略有下降。男性和女性之间观察到的患者生存率差异非常小。儿童癌症的生存率有显著提高。

结论

生存率的提高反映了癌症控制各个领域所取得的进步,从健康教育、早期诊断到治疗和后续护理。本研究为临床医生和卫生管理人员提供了有价值的参考信息,也为针对各个解剖部位患者生存率的更详细研究提供了基线。

相似文献

1
Survival of cancer patients in Finland 1955-1994.1955年至1994年芬兰癌症患者的生存率。
Acta Oncol. 1999;38 Suppl 12:1-103. doi: 10.1080/028418699432996.
2
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
3
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
4
Italian cancer figures, report 2011: Survival of cancer patients in Italy.《2011年意大利癌症数据报告:意大利癌症患者的生存率》
Epidemiol Prev. 2011 Sep-Dec;35(5-6 Suppl 3):1-200.
5
Childhood cancer survival in Finland (1953-2010): a nation-wide population-based study.芬兰儿童癌症存活率(1953-2010):一项全国性基于人群的研究。
Int J Cancer. 2014 Nov 1;135(9):2129-34. doi: 10.1002/ijc.28844. Epub 2014 Apr 2.
6
Cancer patient survival--patterns, comparisons, trends--a population-based Cancer Registry study in Finland.癌症患者生存率——模式、比较、趋势——芬兰一项基于人群的癌症登记研究
Acta Oncol. 1999;38(3):283-94. doi: 10.1080/028418699431348.
7
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.北欧国家癌症发病率趋势。北欧五个癌症登记处的合作研究。
Acta Pathol Microbiol Immunol Scand Suppl. 1986;288:1-151.
8
Decreasing incidence and improved survival of laryngeal cancer in Finland.芬兰喉癌发病率下降且生存率提高。
Acta Oncol. 2001;40(7):791-5. doi: 10.1080/02841860152703391.
9
Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.北欧国家 1964-2003 年间诊断为癌症的患者的生存趋势,随访至 2006 年底。材料和方法。
Acta Oncol. 2010 Jun;49(5):545-60. doi: 10.3109/02841861003739322.
10
Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? A Finnish population-based study.衡量癌症患者生存中的社会阶层差异:是否有必要控制一般人群死亡率中的社会阶层差异?一项基于芬兰人群的研究。
J Epidemiol Community Health. 1998 Nov;52(11):727-34. doi: 10.1136/jech.52.11.727.

引用本文的文献

1
[Not Available].[无可用内容]
Glob Reg Health Technol Assess. 2021 Feb 5;8:1-7. doi: 10.33393/grhta.2021.2178. eCollection 2021 Jan-Dec.
2
Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.丹麦、芬兰、挪威和瑞典的宫颈癌、阴道癌和外阴癌发病和生存趋势及其对治疗的影响。
BMC Cancer. 2022 Apr 26;22(1):456. doi: 10.1186/s12885-022-09582-5.
3
Antihypertensive Drug Use and the Risk of Ovarian Cancer Death among Finnish Ovarian Cancer Patients-A Nationwide Cohort Study.
芬兰卵巢癌患者中抗高血压药物的使用与卵巢癌死亡风险——一项全国性队列研究
Cancers (Basel). 2021 Apr 26;13(9):2087. doi: 10.3390/cancers13092087.
4
Patterns of age disparities in colon and lung cancer survival: a systematic narrative literature review.年龄差异对结肠癌和肺癌生存影响的模式:系统叙述性文献综述。
BMJ Open. 2021 Mar 10;11(3):e044239. doi: 10.1136/bmjopen-2020-044239.
5
Do Cervical Cancer Patients Diagnosed with Opportunistic Screening Live Longer? An Arkhangelsk Cancer Registry Study.机会性筛查诊断的宫颈癌患者是否活得更长?阿尔汉格尔斯克癌症登记研究。
Int J Environ Res Public Health. 2017 Nov 26;14(12):1500. doi: 10.3390/ijerph14121500.
6
Prognostic value of E2F1 in rectal cancer.E2F1在直肠癌中的预后价值。
Turk J Surg. 2017 Sep 1;33(3):180-184. doi: 10.5152/turkjsurg.2017.3576. eCollection 2017.
7
A rare cause in etiology of left atrial mass: metastatic testicular germ cell tumor.左心房肿物病因中的罕见原因:转移性睾丸生殖细胞肿瘤。
Kardiochir Torakochirurgia Pol. 2016 Mar;13(1):45-8. doi: 10.5114/kitp.2016.58965. Epub 2016 Mar 30.
8
Effect of intervention on decision making of treatment for disease progression, prostate-specific antigen biochemical failure and prostate cancer death.干预对疾病进展、前列腺特异性抗原生化失败和前列腺癌死亡的治疗决策的影响。
Health Expect. 2014 Dec;17(6):776-83. doi: 10.1111/j.1369-7625.2012.00802.x. Epub 2012 Jul 19.
9
Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer.胶原酶-2(基质金属蛋白酶-8)在舌癌中发挥保护作用。
Br J Cancer. 2008 Feb 26;98(4):766-75. doi: 10.1038/sj.bjc.6604239. Epub 2008 Feb 5.
10
Head and neck cancer in primary care: presenting symptoms and the effect of delayed diagnosis of cancer cases.基层医疗中的头颈癌:呈现的症状及癌症病例延迟诊断的影响。
CMAJ. 2006 Mar 14;174(6):779-84. doi: 10.1503/cmaj.050623.